Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of NRSNW will rise by +76.30% over the next 2 Weeks and hit $0.16 by Tuesday, November 21, 2023. In that time frame, NRSNW's share price is expected to range between $0.13 and $0.19.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Nov 21, 2023 | 0.13 | 0.16 | 0.19 |
| Nov 20, 2023 | 0.10 | 0.12 | 0.15 |
| Nov 17, 2023 | 0.09 | 0.12 | 0.15 |
| Nov 16, 2023 | 0.11 | 0.13 | 0.16 |
| Nov 15, 2023 | 0.09 | 0.12 | 0.15 |
| Nov 14, 2023 | 0.13 | 0.16 | 0.19 |
| Nov 13, 2023 | 0.09 | 0.12 | 0.15 |
| Nov 10, 2023 | 0.09 | 0.12 | 0.15 |
| Nov 9, 2023 | 0.10 | 0.13 | 0.16 |
| Nov 8, 2023 | 0.09 | 0.12 | 0.14 |
| Nov 7, 2023 | 0.13 | 0.15 | 0.18 |
| Nov 6, 2023 | 0.09 | 0.12 | 0.15 |
| Nov 2, 2023 | 0.10 | 0.13 | 0.16 |
NRSNW shares fell -15.94% in Thursday, June 18, 2026's trading session, dropping from a previous close of $0.11 to move at $0.09. The stock demonstrated notable intraday movement (see NRSNW's key stats for a full breakdown), fluctuating between $0.08 and $0.11, a +42.71% trading range. While recent weeks have seen some volatility, NRSNW has managed to secure a -52.21% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 11.78K shares changing hands, 11.52K more than the previous session. This amounted to $1.07K in total market activity.
Will NRSNW Continue Its Upward Trend?
According to analyst ratings and projections for NRSNW, NeuroSense Therapeutics Ltd. shares are anticipated to increase by +51.22%, potentially reaching $0.19 per share by November 21, 2023. Short-term technical indicators currently suggest a bullish sentiment for NRSNW. However, the stock has recorded 17 negative trading days within the past 30 sessions. Based on the NRSNW stock forecast, now is a good time to buy NRSNW stock because its current trading price is -43.28% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on NRSNW covering social and institutional perspectives.
NRSNW Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into NRSNW's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 40.84% to 44.95%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 46.40%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 47.60%, maintains a neutral outlook for the long term. Insights into NRSNW's shareholder base show how institutional investors are positioning themselves during these momentum shifts

